The Changing Landscape of Journal Performance Measurement
Take advantage of alternative impact metrics that better reflect the multidimensional nature of today’s research dissemination and consumption.
Take advantage of alternative impact metrics that better reflect the multidimensional nature of today’s research dissemination and consumption.
Tim Mikelhashvili, CEO of Amedea Pharma, discusses innovation in Medical Affairs leadership. And previews his 2024 Medical Affairs Innovation Olympics!
Publishing a scientific study can feel like squeezing an eyedropper into the ocean and it is the job of the Publications team to ensure this publication has impact — especially when it has the potential to change clinical practice. Here we learn practical tips straight from the source – namely, experts at Wiley.
By the end of this webinar, attendees should...
1. Be able to articulate why it’s important to consider a patient community audience when planning scientific and data dissemination including incorporating their voice within it.
2. Be confident to follow clear methodologies to incorporate the patient voice within publications and the role of Medical Affairs in disease awareness campaigns.
3. Be able to implement best practice approaches including novel ways to disseminate information.
In an era when regulatory approvals for new products are rapidly increasing and customers are feeling overwhelmed by new medical information, they are increasingly seeking immediate answers to specific questions. As a result, the need for high-quality, relevant, timely medical information is skyrocketing and the Medical Information function (MI) is rapidly evolving—or trying to—in terms of how the external service operates and its role internally.
With companies driving their own engagement and alternatives to journals becoming mainstream, does impact factor still matter?
Omnichannel communication holds the promise of reshaping interactions between the pharmaceutical industry and healthcare professionals (HCPs), revolutionizing engagement through personalized and seamless connections. Medical Affairs teams are in a unique position to engage with and provide HCPs with the information and education they seek, including in-depth clinical data, additional analyses and treatment updates. While Medical Affairs teams have the capacity to harness this transformative power, the pharmaceutical industry has been slow to fully embrace this revolution. Crafting effective omnichannel strategies remains a formidable challenge, laden with barriers.
Our webinar offers a platform for attendees to engage with a diverse group of Medical Affairs omnichannel experts, discover their distinctive perspectives, navigate common obstacles, and gain firsthand insights into pragmatic omnichannel integration solutions.
Key areas of focus will include:
·     Unpacking Omnichannel Strategies: Understanding the added value for customers and organizations, and the need to diverge from conventional single or multichannel approaches
·     Overcoming Barriers: Identifying and surmounting the obstacles hindering Medical Affairs teams' success with omnichannel, and exploring actionable solutions
·     Forging the Path to Omnichannel Success: Strategic drivers and actions, and how to institute them effectively across organizational landscapes.
This article addresses the metrics that Medical Affairs can use to measure how effectively they communicate on their strategic imperatives, with a specific focus on Share of Scientific Voice (SoSV).
The MAPS Puerto Rico Roundtable hosted by Real Chemistry in March 2024 discussed the integration of digital platforms, AI, and personalized content to enhance engagement with healthcare providers (HCPs). The panel emphasized the shift towards real-time, tailored information delivery and the importance of leveraging insights from both traditional and digital sources to support effective engagement strategies while ensuring compliance.
The Medical Affairs landscape is rapidly evolving, demanding field medical teams to engage with a wide range of stakeholders. MSLs are expected to handle over 350 interactions annually and manage numerous stakeholders, a number which continues to rise. However, simply increasing interaction numbers without addressing associated challenges like reaching out to the right stakeholders or gaining access to them is ineffective. It's crucial for organizations to acknowledge and tackle these obstacles effectively. By doing so, they can redefine engagement strategies, ensuring meaningful interactions tailored to stakeholders' needs. This approach will allow organizations to move beyond mere volume-based metrics, focusing instead on the genuine productivity and impact of their field medical teams. Over the course of time, this will also lead to better relationships being developed with key scientific stakeholders.
This webinar discusses the current focus on volume-based metrics as a measure and will also help the participants understand some key considerations around volume-based metrics while redefining the industry thinking on this important topic.
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.